SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-24-001769
Filing Date
2024-06-21
Accepted
2024-06-21 17:05:08
Documents
1
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3593
  Complete submission text file 0000905148-24-001769.txt   5020
Mailing Address C/O OPTIMER PHARMACEUTICALS, INC 101 HUDSON STREET SAN DIEGO CA 07302
Business Address
Webster Stephen W (Reporting) CIK: 0001438421 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38905 | Film No.: 241061294

Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)